Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: Effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy

European Radiology

Volumn 22, Issue 12, 2012, Pages 2633-2640

  Hegenscheid, Katrin ^a   Schmidt, Carsten O ^a   Seipel, Rebecca ^a   Laqua, René ^a   Ohlinger, Ralf ^a   Hosten, Norbert ^a   Puls, Ralf ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Breast; Contrast media; Magnetic resonance imaging; Oral contraceptives; Postmenopausal hormone therapy

Indexed keywords

GADOBUTROL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAGNETIC RESONANCE MAMMOGRAPHY; MAMMOGRAPHY; MENOPAUSE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRACEPTIVES, ORAL; CONTRAST MEDIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MENOPAUSE; ORGANOMETALLIC COMPOUNDS; PREMENOPAUSE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84870310505     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2544-9     Document Type: Article

References (36)

1. Hauth EAM, Jaeger H, Maderwald S et al (2006) Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography. Eur Radiol 16: 2834-2841
2. Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203: 137-144
3. American College of Radiology (2003) ACR Breast Imaging- Reporting and Data System (BI-RADS): breast MRI atlas, 4th ed. American College of Radiology, Reston, V.A.
4. Sardanelli F, Podo F (2007) Breast MR imaging in women at highrisk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 17: 873-887
5. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS (2007) Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 245: 684-691
6. Teifke A, Lehr H, Vomweg T, Hlawatsch A, Thelen M (2003) Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 181: 655-662
7. Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval followup. AJR Am J Roentgenol 196: 218-224
8. Baltzer PA, Dietzel M, Vag T et al (2011) Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Rofo 183: 441-447
9. Uematsu T, Kasami M, Watanabe J (2011) Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer? Eur Radiol 21: 2261-2267
10. Pfleiderer SOR, Sachse S, Sauner D (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232-238
11. Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM (2011) Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol 21: 1374-1382
12. Chan S, Su M-YL, Lei F-J et al (2011) Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. Radiology 261: 744-751
13. Hussain Z, Roberts N, Whitehouse GH, García-Fiñana M, Percy D (1999) Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. Br J Radiol 72: 236-245
14. Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB (1995) Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 5: 695-701
15. Dean KI, Majurin ML, Komu M (1994) Relaxation times of normal breast tissues. Changes with age and variations during the menstrual cycle. Acta Radiol 35: 258-261
16. O'Flynn EAM, Morgan VA, Giles SL, Desouza NM (2012) Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status. Eur Radiol 22(7): 1512-1518
17. Müller-Schimpfle M, Ohmenhaüser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203: 145-149
18. Delille J-P, Slanetz PJ, Yeh ED, Kopans DB, Garrido L (2005) Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 11: 236-241
19. Rieber A, Nüssle K, Merkle E, Kreienberg R, Tomczak R, Brambs HJ (1999) MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease. Eur Radiol 9: 1107-1112
20. Boyd NF, Melnichouk O, Martin LJ et al (2011) Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol 29: 2985-2992
21. Reichenbach JR, Przetak C, Klinger G, Kaiser WA (1999) Assessment of breast tissue changes on hormonal replacement therapy using MRI: a pilot study. J Comput Assist Tomogr 23: 407-413
22. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging - initial observations. Radiology 235: 36-41
23. Völzke H, Alte D, Schmidt CO et al (2011) Cohort profile: the study of health in Pomerania. Int J Epidemiol 40: 294-307
24. Hegenscheid K, Kühn JP, Volzke H, Biffar R, Hosten N, Puls R (2009) Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. Rofo 181: 748-759
25. Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170: 681-686
26. Snijders T, Bosker R (1999) Multilevel analysis: an introduction to basic and advances multilevelmodeling. Sage Publications, London
27. Hulka CA, Smith BL, Sgroi DC et al (1995) Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 197: 33-38
28. Hulka CA, Edmister WB, Smith BL (1997) Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205: 837-842
29. Zeppa R (1969) Vascular response of the breast to estrogen. J Clin Endocrinol Metab 29: 695-700
30. Potten CS, Watson RJ, Williams GT et al (1988) The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163-170
31. Teifke A, Hlawatsch A, Beier T et al (2002) Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 224: 881-888
32. Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA (2003) High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 76: 3-12
33. Marklund M, Christensen R, Torp-Pedersen S, Thomsen C, Nolsøe CP (2009) Signal intensity of normal breast tissue at MR mammography on midfield: applying a random coefficient model evaluating the effect of doubling the contrast dose. Eur J Radiol 69: 93-101
34. Kulier R, Helmerhorst FM, Maitra N, Gülmezoglu AM (2004) Effectiveness and acceptability of progestogens in combined oral contraceptives - a systematic review. Reprod Health 1: 1
35. Fujimoto J, Sakaguchi H, Hirose R, Tamaya T (1998) Sex steroidal regulation of vessel permeability associated with vessel endothelial cadherin (V-cadherin). J Steroid Biochem Mol Biol 67: 25-32
36. Wang J, Jiang C, Li X, Liu C, Cheng N, Hao Y (2009) The protective mechanism of progesterone on blood-brain barrier in cerebral ischemia in rats. Brain Res Bull 79: 426-430